A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1568-1573

  Herman, William H ^a   Ilag, Liza L ^b   Johnson, Susan L ^b   Martin, Catherine L ^b   Sinding, Joyce ^c   Al Harthi, Abdulaziz ^b   Plunkett, Cynthia D ^b   LaPorte, Frankie B ^d   Burke, Ray ^b   Brown, Morton B ^d   Halter, Jeffery B ^b   Raskin, Philip ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; INSULIN LISPRO;

ADULT; AGED; AGING; ARTICLE; BLEEDING; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INFLAMMATION; INFUSION PUMP; INJECTION; INJECTION SITE REACTION; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEEDLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SIDE EFFECT; SKIN IRRITATION; SYRINGE; WEIGHT GAIN; WOUND;

DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; WEIGHT GAIN;

EID: 21544436847     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1568     Document Type: Article

References (21)

1. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer H, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 21:518-524, 1998
2. Menielly GS, Tessier D: Diabetes in elderly adults. J Gerontol 56A:M5-M13, 2001
3. United Kingdom Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment on risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
4. Ohkubo Y, Kishikawa H, Araki EM, T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin thereapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res and Clinical Practice 27:103-117, 1995
5. American Diabetes Association: Standards of medical care in diabetes (Position Statement). Diabetes Care 27 (Suppl. 1): S15-S35, 2004
6. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes: guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 51:5265-5280, 2003
7. Shorr RI, Franse L, Resnick HE, Di Bari M, Johnson KC, Pahor M: Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc 48:264-267, 2000
8. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli G: Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49:2142-2148, 2000
9. Doyle E, Weinzimer S, Steffen A, Ahern J, Vincent M, Tamborlane W: A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27: 1554-1558, 2004
10. DeVries J, Snoek F, Kostense P, Masurel N, Heine R: A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 25:2074-2080, 2002
11. Tsu iE, Barnie A, Ross S, Parkes R, Zinman B: Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 24:1722-1727, 2001
12. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber J: Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. Diabetes Care 23:1232-1235, 2000
13. Raskin P, Bode B, Marks J, Hirsch I, Weinstein R, McGill J, Peterson G, Mudaliar S, Reinhardt R: Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 26:2598-2603, 2003
14. Shen W, Kotsanos J, Huster W, Mathias S, Andrejasich C, Patrick D: Development and validation of the Diabetes Quality of Life Clinical Trial Questionnaire. Med Care 37:AS45-AS66, 1999
15. Ware J, Sherbourne C: The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care 30:473-483, 1992
16. Retnakaran R, Hochman J, DeVries J, Hanaire-Broutin H, Heine R, Melki V, Zinman B: Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1C. Diabetes Care 27:2590-2596, 2004
17. Chelliah A, Burge M: Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging 21:511-530, 2004
18. Meneilly G, Cheung E, Tuokko H: Altered responses to hypoglycemia of healthy elderly people. J Clin Endocrinol Metab 78: 1341-1348, 1994
19. Marker J, Cryer P, Clutter W: Attenuated glucose recovery from hypoglycemia in the elderly. Diabetes 41:671-678, 1992
20. Meneilly G, Cheung E, Tuokko H: Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes 4310:403-410, 1994
21. The Diabetes Control and Complications Trial Research Group: Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care 18:1468-1478, 1995